Immunohistological analysis of B7-H4, IDO1, and PD-L1 expression and tumor immune microenvironment based on triple-negative breast cancer subtypes

被引：0
|
作者：
Fumiaki Sanuki
Yuka Mikami
Hirotake Nishimura
Yoshinori Fujita
Yasumasa Monobe
Tsunehisa Nomura
Naruto Taira
Takuya Moriya
机构：
[1] Kawasaki Medical School,Department of Pathology
[2] Kawasaki Medical School General Medical Center,Department of Pathology
[3] Kawasaki Medical School,Department of Breast and Thyroid Surgery
来源：
Breast Cancer | 2023年 / 30卷
关键词：
Breast cancer; Triple-negative breast cancer; Immune checkpoint molecules; Immune checkpoint inhibitors; Tumor-infiltrating lymphocytes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1041 / 1053
页数：12
相关论文
共 50 条
  • [21] Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies
    Woo Young Sun
    Yu Kyung Lee
    Ja Seung Koo
    Journal of Translational Medicine, 14
  • [22] PD-L1 expression in tumor infiltrated lymphocytes predicts survival in triple-negative breast cancer
    Wang Xinran
    Liu, Yueping
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (03)
  • [23] Prognostic significance of PD-L1 expression on cancer, stromal, or immune cells in triple-negative breast cancer
    Behrendt, Carolyn E.
    Schmolze, Daniel B.
    Lee, Peter P.
    Apple, Sophia
    LABORATORY INVESTIGATION, 2018, 98 : 50 - 50
  • [24] Prognostic significance of PD-L1 expression on cancer, stromal, or immune cells in triple-negative breast cancer
    Behrendt, Carolyn E.
    Schmolze, Daniel B.
    Lee, Peter P.
    Apple, Sophia
    MODERN PATHOLOGY, 2018, 31 : 50 - 50
  • [25] Role of PD-L1 expression in triple-negative breast cancer stem cells
    Di Nicola, Massimo A.
    Castagnoli, Lorenzo
    Cancila, Valeria
    Romero, Sandra
    Faraci, Simona
    Chiodoni, Claudia
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [26] Assessment of PD-L1 expression and tumor-infiltrating lymphocytes (TILs) across molecular subtypes of triple-negative breast cancer
    Sood, Ridhi
    Kumar, Sandeep
    Laroiya, Ishita
    Khare, Siddhant
    Das, Ashim
    Singh, Gurpreet
    Bal, Amanjit
    BREAST JOURNAL, 2020, 26 (12): : 2424 - 2427
  • [27] Clinicopathological significance of PD-L1 expression in patients with triple-negative breast cancer
    Basheska, N.
    Ognenoska-Jankovska, B.
    HISTOPATHOLOGY, 2022, 81 : 26 - 27
  • [28] The effect of cardamonin on PD-L1 expression in triple-negative breast cancer cells
    Mendonca, Patricia
    Kirpal, Bhonessa
    Kaur, Sukhmandeep
    Soliman, Karam F. A.
    CANCER RESEARCH, 2024, 84 (06)
  • [29] BRD4 inhibition suppresses PD-L1 expression in triple-negative breast cancer
    Jing, Xin
    Shao, Shan
    Zhang, Yujiao
    Luo, Anqi
    Zhao, Lin
    Zhang, Lifen
    Gu, Shanzhi
    Zhao, Xinhan
    EXPERIMENTAL CELL RESEARCH, 2020, 392 (02)
  • [30] PD1, PD-L1 and PD-L2 mRNA Expression in triple-negative Breast Cancer
    Schueler, K.
    Bethmann, D.
    Staege, M.
    Kantelhardt, J. E.
    Thomssen, C.
    Vetter, M.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (06) : E24 - E24
12345